What is the recommended prophylaxis for Yersinia pestis exposure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Prophylaxis for Yersinia pestis Exposure

Bold recommendation: Give 7 days of single‑agent oral prophylaxis with a first‑line fluoroquinolone (ciprofloxacin or levofloxacin) or doxycycline, started as soon as possible after qualifying exposure; stop pre‑exposure prophylaxis 48 hours after last perceived exposure. 1

Who should receive post‑exposure prophylaxis (PEP)

  • Close (<6 feet), sustained, unprotected contact with a pneumonic plague patient; certain lab accidents; direct/close contact with infected animals (e.g., veterinary exposure). 1

Regimens (choose ONE agent; do not combine for prophylaxis)

  • Adults (≥18 years) first‑line:

    • Ciprofloxacin 500–750 mg PO every 12 h, or
    • Levofloxacin 500–750 mg PO every 24 h, or
    • Moxifloxacin 400 mg PO every 24 h, or
    • Doxycycline 100 mg PO every 12 h. 1
  • Children (≥1 month to ≤17 years) first‑line:

    • Ciprofloxacin 15 mg/kg PO every 12 h (max 750 mg/dose), or
    • Levofloxacin: <50 kg: 8 mg/kg PO every 12 h (max 250 mg/dose); ≥50 kg: 500–750 mg PO every 24 h, or
    • Doxycycline: <45 kg: 2.2 mg/kg PO every 12 h; ≥45 kg: 100 mg PO every 12 h. 1
  • Pregnancy (PEP mirrors nonpregnant, but prefer fluoroquinolones):

    • First‑line: Ciprofloxacin 500 mg PO every 8 h or 750 mg PO every 12 h; Levofloxacin 750 mg PO every 24 h.
    • Alternatives: Moxifloxacin 400 mg PO every 24 h; Ofloxacin 400 mg PO every 12 h; Doxycycline 100 mg PO every 12 h; TMP‑SMX 5 mg/kg (TMP) PO every 12 h. [1–1]
  • Duration:

    • Post‑exposure prophylaxis: 7 days.
    • Pre‑exposure prophylaxis (for ongoing high‑risk operations): discontinue 48 hours after last perceived exposure. 1
  • Alternatives if first‑line not available/tolerated (adults/children): Ofloxacin, gemifloxacin (adults), tetracycline, minocycline, omadacycline (adults), trimethoprim‑sulfamethoxazole (weight‑based). Use when appropriate to patient age and contraindications. 1

Rationale prioritizing morbidity, mortality, and QOL

  • CDC 2021 MMWR guidelines (most recent, high‑quality) recommend single‑agent oral prophylaxis to prevent rapidly fatal pneumonic plague; timing and adherence directly impact mortality prevention. 1
  • Experimental data favor fluoroquinolones over doxycycline for inhalational exposures; ciprofloxacin PEP showed superior protection in animal models, supporting choice when feasible. 2, 3

Implementation steps

  1. Confirm qualifying exposure and start PEP immediately; do not wait for symptoms. 1
  2. Select first‑line agent above; adjust for age, pregnancy, QT risk (moxifloxacin), dental risks with tetracyclines in young children, and sulfonamide cautions in early pregnancy. 1
  3. Educate on strict 7‑day adherence; monitor for fever, cough, dyspnea—if symptoms develop, switch to full treatment (not prophylaxis) and isolate for suspected pneumonic plague. 1
  4. Use PPE and patient isolation; prophylaxis does not replace protective measures. 1
  5. If engineered resistance suspected (bioterrorism), target agent selection to susceptibility data as they become available. 1

Common pitfalls and how to avoid them

  • Delayed start of PEP after high‑risk exposure → start immediately to reduce mortality. 1
  • Using dual antibiotics for prophylaxis → monotherapy only; reserve dual therapy for treatment. 1
  • Stopping too soon → complete 7 days for PEP; for pre‑exposure use, stop 48 h after last exposure. 1
  • Inappropriate pediatric tetracycline use (<8 years) when safer options exist → prefer fluoroquinolones or TMP‑SMX when indicated. 1
  • Ignoring QT risk with moxifloxacin or using ciprofloxacin via feeding tubes (not recommended) → choose alternative agents/routes accordingly. 1

Notes on evidence strength and nuances

  • 2021 CDC MMWR guidelines are the most recent, comprehensive, and authoritative source guiding prophylaxis. [1–1]
  • Animal data suggest ciprofloxacin superiority over doxycycline for aerosolized exposure; nonetheless, guidelines list both as first‑line, enabling practical, life‑saving options when availability varies. 2, 3, 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.